Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC determined ineligible for PD(L)1 therapy based on PD-L1 negative disease

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy... Read More


Singapore Clinical Trial: PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2 arm parallel-group, double-blind, placebo-controlled basket trial to assess safety, tolerability, PK, and efficacy of BI 764198 in four proteinuric kidney diseases

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'PODOMOUNT-Basket, a Phase II, multicentre, randomised, 2 arm parallel-group, double-blind, placeb... Read More


Singapore Clinical Trial: Bepirovirsen Liver Biopsy study

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Bepirovirsen Liver Biopsy study'. The following are the other relevant details related to the tri... Read More


Singapore Clinical Trial: CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxel and Gemcitabine versus Placebo in Combination with Nab-paclitaxel and Gemcitabine in Participants with Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... Read More


Singapore Clinical Trial: A randomised phase III trial of adjuvant cemiplimab in patients with resected stage IIA-IIIB NSCLC who have not received prior adjuvant chemotherapy

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A randomised phase III trial of adjuvant cemiplimab in patients with resected stage IIA-IIIB NSCL... Read More


Singapore Clinical Trial: Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children with Hypochondroplasia: ACCEL OLE

Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyro... Read More


Clinical Trial: A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (MK-7962-041)

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839585) titled 'A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precap... Read More


Clinical Trial: Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07840092) titled 'Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Ca... Read More


Clinical Trial: A Pilot Study Comparison of Programmed Intermittent Bolus Versus Continuous Infusion

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839039) titled 'A Pilot Study Comparison of Programmed Intermittent Bolus Versus Continuous Infusion' on S... Read More


Clinical Trial: Enhancing Emotion Regulation in Children With Autism Through Extended Reality

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838272) titled 'Enhancing Emotion Regulation in Children With Autism Through Extended Reality' on Aug. 24.... Read More